Search Page

1

Cite

Share

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. Fazekas F, et al. Among authors: hurtig hi. AJR Am J Roentgenol. 1987 Aug;149(2):351-6. doi: 10.2214/ajr.149.2.351. AJR Am J Roentgenol. 1987. PMID: 3496763

Cite

Share

2

Cite

Share

Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Coughlin DG, Hurtig HI, Irwin DJ. Coughlin DG, et al. Among authors: hurtig hi. Mov Disord. 2020 Jan;35(1):5-19. doi: 10.1002/mds.27867. Epub 2019 Oct 29. Mov Disord. 2020. PMID: 31660655 Free PMC article. Review.

Cite

Share

3

Cite

Share

John Q. Trojanowski, MD, PhD (1946-2022).

Hurtig HI, Standaert DG. Hurtig HI, et al. Mov Disord. 2022 Jun;37(6):1123-1124. doi: 10.1002/mds.29053. Mov Disord. 2022. PMID: 35707825 No abstract available.

Cite

Share

4

Cite

Share

Current understanding and management of Parkinson disease: five new things.

Morley JF, Hurtig HI. Morley JF, et al. Among authors: hurtig hi. Neurology. 2010 Nov 2;75(18 Suppl 1):S9-15. doi: 10.1212/WNL.0b013e3181fb3628. Neurology. 2010. PMID: 21041778 Review. No abstract available.

Cite

Share

5

Cite

Share

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.

Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ. Robinson JL, et al. Among authors: hurtig hi. Brain. 2018 Jul 1;141(7):2181-2193. doi: 10.1093/brain/awy146. Brain. 2018. PMID: 29878075 Free PMC article.

Cite

Share

6

Cite

Share

Palliative care in amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis.

Elman LB, Houghton DJ, Wu GF, Hurtig HI, Markowitz CE, McCluskey L. Elman LB, et al. Among authors: hurtig hi. J Palliat Med. 2007 Apr;10(2):433-57. doi: 10.1089/jpm.2006.9978. J Palliat Med. 2007. PMID: 17472516 Review.

Cite

Share

7

Cite

Share

Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.

Coughlin DG, Ittyerah R, Peterson C, Phillips JS, Miller S, Rascovsky K, Weintraub D, Siderowf AD, Duda JE, Hurtig HI, Wolk DA, McMillan CT, Yushkevich PA, Grossman M, Lee EB, Trojanowski JQ, Irwin DJ. Coughlin DG, et al. Among authors: hurtig hi. Neuropathol Appl Neurobiol. 2020 Dec;46(7):707-721. doi: 10.1111/nan.12659. Epub 2020 Sep 24. Neuropathol Appl Neurobiol. 2020. PMID: 32892355 Free PMC article.

Cite

Share

8

Cite

Share

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Hu WT, et al. Among authors: hurtig hi. Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Epub 2010 Jul 22. Acta Neuropathol. 2010. PMID: 20652578 Free PMC article. Review.

Cite

Share

9

Cite

Share

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.

Goldmann Gross R, Siderowf A, Hurtig HI. Goldmann Gross R, et al. Among authors: hurtig hi. Neurosignals. 2008;16(1):24-34. doi: 10.1159/000109756. Epub 2007 Dec 5. Neurosignals. 2008. PMID: 18097157 Free article. Review.

Cite

Share

10

Cite

Share

Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management.

Halpern CH, Torres N, Hurtig HI, Wolf JA, Stephen J, Oh MY, Williams NN, Dichter MA, Jaggi JL, Caplan AL, Kampman KM, Wadden TA, Whiting DM, Baltuch GH. Halpern CH, et al. Among authors: hurtig hi. Acta Neurochir (Wien). 2011 Dec;153(12):2293-306. doi: 10.1007/s00701-011-1166-3. Acta Neurochir (Wien). 2011. PMID: 21976235 Review.

Cite

Share